Malignant rhabdoid tumors express stem cell factors, which relate to the expression of Ezh2 and Id proteins

American Journal of Surgical Pathology

Volumn 35, Issue 10, 2011, Pages 1463-1472

  Venneti, Sriram ^a   Le, Paul ^b   Martinez, Daniel ^b   Xie, Sharon X ^b   Sullivan, Lisa M ^b   Rorke Adams, Lucy B ^b   Pawel, Bruce ^b   Judkins, Alexander R ^c  

^a Department of Pathology and Laboratory Medicine ^*  (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

EZH2; Id proteins; polycomb proteins; rhabdoid tumor; stem cell factors

Indexed keywords

DNA BINDING PROTEIN; EZH2 PROTEIN, HUMAN; ID1 PROTEIN, HUMAN; INHIBITOR OF DIFFERENTIATION 1; TRANSCRIPTION FACTOR; TUMOR MARKER;

ADULT; ARTICLE; BRAIN TUMOR; CANCER STEM CELL; CHILD; FEMALE; HUMAN; INFANT; MALE; METABOLISM; PATHOLOGY; PRESCHOOL CHILD; RHABDOID TUMOR; TERATOMA; TISSUE MICROARRAY;

ADULT; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; FEMALE; HUMANS; INFANT; INHIBITOR OF DIFFERENTIATION PROTEIN 1; MALE; NEOPLASTIC STEM CELLS; RHABDOID TUMOR; TERATOMA; TISSUE ARRAY ANALYSIS; TRANSCRIPTION FACTORS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 80053371262     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318224d2cd     Document Type: Article

References (61)

1. Abaskharoun M, Bellemare M, Lau E, et al. Glypican-1, phosphacan/receptor protein-tyrosine phosphatase-zeta/beta and its ligand, tenascin-C, are expressed by neural stem cells and neural cells derived from embryonic stem cells. ASN Neuro. 2:e00039
2. Akamatsu W, DeVeale B, Okano H, et al. Suppression of Oct4 by germ cell nuclear factor restricts pluripotency and promotes neural stem cell development in the early neural lineage. J Neurosci. 2009;29:2113-2124
3. Alani RM, Young AZ, Shifflett CB. Id1 regulation of cellular senescence through transcriptional repression of p16/Ink4a. Proc Natl Acad Sci U S A. 2001;98:7812-7816 (Pubitemid 32642643)
4. Ben-Porath I, Thomson MW, Carey VJ, et al. An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors. Nat Genet. 2008;40:499-507 (Pubitemid 351601215)
5. Betz BL, Strobeck MW, Reisman DN, et al. Re-expression of hSNF5/INI1/BAF47 in pediatric tumor cells leads to G1 arrest associated with induction of p16ink4a and activation of RB. Oncogene. 2002;21:5193-5203 (Pubitemid 34948131)
6. Biegel JA, Zhou JY, Rorke LB, et al. Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors. Cancer Res. 1999;59:74-79 (Pubitemid 29062960)
7. Bracken AP, Helin K. Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer. 2009;9: 773-784
8. Bracken AP, Dietrich N, Pasini D, et al. Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions. Genes Dev. 2006;20:1123-1136
9. Cao R, Zhang Y. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev. 2004;14: 155-164 (Pubitemid 38520143)
10. Cao D, Guo S, Allan RW, et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am J Surg Pathol. 2009;33:894-904
11. Cao D, Humphrey PA, Allan RW. SALL4 is a novel sensitive and specific marker for metastatic germ cell tumors, with particular utility in detection of metastatic yolk sac tumors. Cancer. 2009;115:2640-2651
12. Cao D, Li J, Guo CC, et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am J Surg Pathol. 2009;33:1065-1077
13. Chai J, Charboneau AL, Betz BL, et al. Loss of the hSNF5 gene concomitantly inactivates p21CIP/WAF1 and p16INK4a activity associated with replicative senescence in A204 rhabdoid tumor cells. Cancer Res. 2005;65:10192-10198 (Pubitemid 41743710)
14. Deisch J, Raisanen J, Rakheja D. Immunohistochemical expression of embryonic stem cell markers in malignant rhabdoid tumors. Pediatr Dev Pathol. 2011 [Epub ahead of print]
15. Eaton KW, Tooke LS, Wainwright LM, et al. Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer. 2011;56:7-15
16. Fanburg-Smith JC, Hengge M, Hengge UR, et al. Extrarenal rhabdoid tumors of soft tissue: a clinicopathologic and immunohistochemical study of 18 cases. Ann Diagn Pathol. 1998;2:351-362 (Pubitemid 128654506)
17. Gadd S, Sredni ST, Huang CC, et al. Rhabdoid tumor: gene expression clues to pathogenesis and potential therapeutic targets. Lab Invest. 2010;90:724-738
18. Isakoff MS, Sansam CG, Tamayo P, et al. Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation. Proc Natl Acad Sci U S A. 2005;102:17745-17750 (Pubitemid 41803568)
19. Jackson EM, Sievert AJ, Gai X, et al. Genomic analysis using highdensity single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res. 2009;15:1923-1930
20. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008;132:567-582 (Pubitemid 351253686)
21. Judkins AR, Mauger J, Ht A, et al. Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol. 2004;28:644-650 (Pubitemid 38579568)
22. Judkins AR, Eberhart CG, Wesseling P. Atypical teratoid/rhabdoid tumor. WHO Classification of Tumors of the Central Nervous System. 2007;4:147-149
23. Jung S, Park RH, Kim S, et al. Id proteins facilitate self-renewal and proliferation of neural stem cells. Stem Cells Dev. 2010;19:831-841
24. Kaneko Y, Sakakibara S, Imai T, et al. Musashi1: an evolutionally conserved marker for CNS progenitor cells including neural stem cells. Dev Neurosci. 2000;22:139-153 (Pubitemid 30098914)
25. Kato H, Honma R, Sanda T, et al. Knock down of hSNF5/Ini1 causes cell cycle arrest and apoptosis in a p53-dependent manner. Biochem Biophys Res Commun. 2007;361:580-585 (Pubitemid 47238026)
26. Kim JB, Greber B, Arauzo-Bravo MJ, et al. Direct reprogramming of human neural stem cells by OCT4. Nature. 2009;461:649-643
27. Klochendler-Yeivin A, Fiette L, Barra J, et al. The murine SNF5/ INI1 chromatin remodeling factor is essential for embryonic development and tumor suppression. EMBO Rep. 2000;1:500-506
28. Lang KC, Lin IH, Teng HF, et al. Simultaneous overexpression of Oct4 and Nanog abrogates terminal myogenesis. Am J Physiol Cell Physiol. 2009;297:C43-54
29. Lasorella A, Noseda M, Beyna M, et al. Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature. 2000;407:592-598
30. Liu A, Cheng L, Du J, et al. Diagnostic utility of novel stem cell markers SALL4, OCT4, NANOG, SOX2, UTF1, and TCL1 in primary mediastinal germ cell tumors. Am J Surg Pathol. 2010;34: 697-706
31. Macarthur BD, Ma'ayan A, Lemischka IR. Systems biology of stem cell fate and cellular reprogramming. Nat Rev Mol Cell Biol. 2009;10:672-681
32. Matoba R, Niwa H, Masui S, et al. Dissecting Oct3/4-regulated gene networks in embryonic stem cells by expression profiling. PLoS One. 2006;1:e26
33. Mei K, Liu A, Allan RW, et al. Diagnostic utility of SALL4 in primary germ cell tumors of the central nervous system: a study of 77 cases. Mod Pathol. 2009;22:1628-1636
34. Nishimori H, Sasaki Y, Yoshida K, et al. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors. Oncogene. 2002;21:8302-8309 (Pubitemid 35477870)
35. Nishimoto M, Miyagi S, Yamagishi T, et al. Oct-3/4 maintains the proliferative embryonic stem cell state via specific binding to a variant octamer sequence in the regulatory region of the UTF1 locus. Mol Cell Biol. 2005;25:5084-5094 (Pubitemid 40781108)
36. Ohtani N, Zebedee Z, Huot TJ, et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature. 2001;409:1067-1070 (Pubitemid 32204062)
37. Okuno K, Ohta S, Kato H, et al. Expression of neural stem cell markers in malignant rhabdoid tumor cell lines. Oncol Rep. 2010;23:485-492
38. Oruetxebarria I, Venturini F, Kekarainen T, et al. P16INK4a is required for hSNF5 chromatin remodeler-induced cellular senescence in malignant rhabdoid tumor cells. J Biol Chem. 2004;279: 3807-3816 (Pubitemid 38140626)
39. Reisman D, Glaros S, Thompson EA. The SWI/SNF complex and cancer. Oncogene. 2009;28:1653-1668
40. Roberts CW, Biegel JA. The role of SMARCB1/INI1 in development of rhabdoid tumor. Cancer Biol Ther. 2009;8:412-416
41. Roberts CW, Galusha SA, McMenamin ME, et al. Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice. Proc Natl Acad Sci U S A. 2000;97: 13796-13800
42. Rorke LB, Packer R, Biegel J. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood. J Neurooncol. 1995;24:21-28
43. Rorke LB, Packer RJ, Biegel JA. Central nervous system atypical teratoid/rhabdoid tumors of infancy and childhood: definition of an entity. J Neurosurg. 1996;85:56-65 (Pubitemid 26195038)
44. Ruzinova MB, Benezra R. Id proteins in development, cell cycle and cancer. Trends Cell Biol. 2003;13:410-418 (Pubitemid 36897645)
45. Sikder HA, Devlin MK, Dunlap S, et al. Id proteins in cell growth and tumorigenesis. Cancer Cell. 2003;3:525-530 (Pubitemid 36808647)
46. Simon JA, Lange CA. Roles of the EZH2 histone methyltransferase in cancer epigenetics. Mutat Res. 2008;647:21-29
47. Takahashi K, Tanabe K, Ohnuki M, et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872 (Pubitemid 350138099)
48. Versteege I, Sevenet N, Lange J, et al. Truncating mutations of hSNF5/ INI1 in aggressive paediatric cancer. Nature. 1998;394:203-206 (Pubitemid 28325977)
49. Wang ZX, Teh CH, Kueh JL, et al. Oct4 and Sox2 directly regulate expression of another pluripotency transcription factor, Zfp206, in embryonic stem cells. J Biol Chem. 2007;282:12822-12830 (Pubitemid 47100646)
50. Wang F, Liu A, Peng Y, et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alphafetoprotein, and glypican-3. Am J Surg Pathol. 2009;33:1529-1539
51. Wesseling P, Biegel JA, Eberhart CG, et al. Rhabdoid tumor predisposition syndrome. WHO Classification of Tumors of the Central Nervous System. 2007;4:234-235
52. Wilson BG, Wang X, Shen X, et al. Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation. Cancer Cell. 2010;18:316-328
53. Winter C, Pawel B, Seiser E, et al. Neural cell adhesion molecule (NCAM) isoform expression is associated with neuroblastoma differentiation status. Pediatr Blood Cancer. 2008;51:10-16 (Pubitemid 351717383)
54. Wong DJ, Segal E, Chang HY. Stemness, cancer and cancer stem cells. Cell Cycle. 2008;7:3622-3624
55. Yang J, Gao C, Chai L, et al. A novel SALL4/OCT4 transcriptional feedback network for pluripotency of embryonic stem cells. PLoS One. 2010;5:e10766
56. Ying QL, Nichols J, Chambers I, et al. BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell selfrenewal in collaboration with STAT3. Cell. 2003;115:281-292 (Pubitemid 37487702)
57. Yu HB, Kunarso G, Hong FH, et al. Zfp206, Oct4, and Sox2 are integrated components of a transcriptional regulatory network in embryonic stem cells. J Biol Chem. 2009;284:31327-31335
58. Zafarana G, Avery SR, Avery K, et al. Specific knockdown of OCT4 in human embryonic stem cells by inducible short hairpin RNA interference. Stem Cells. 2009;27:776-782
59. Zhang J, Tam WL, Tong GQ, et al. Sall4 modulates embryonic stem cell pluripotency and early embryonic development by the transcriptional regulation of Pou5f1. Nat Cell Biol. 2006;8:1114-1123 (Pubitemid 44473607)
60. Zynger DL, Dimov ND, Luan C, et al. Glypican 3: a novel marker in testicular germ cell tumors. Am J Surg Pathol. 2006;30:1570-1575 (Pubitemid 44808793)
61. Zynger DL, Everton MJ, Dimov ND, et al. Expression of glypican 3 in ovarian and extragonadal germ cell tumors. Am J Clin Pathol. 2008;130:224-230